Dr. Christopher Lavergne, MD
What this data tells you about Dr. Lavergne
Dr. Christopher Lavergne is a cardiovascular disease in The Woodlands, TX, with 20 years in practice. Based on federal Medicare data, Dr. Lavergne performed 5,898 Medicare services across 3,741 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lavergne received a total of $117,646 from 25 pharmaceutical and/or device companies across 194 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lavergne is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 942 | $86 | $210 |
| Electrocardiogram (EKG), 12-lead | 847 | $10 | $90 |
| Regadenoson injection (Lexiscan) for heart stress test | 762 | $42 | $125 |
| EKG interpretation and report | 396 | $6 | $50 |
| Injection of chemical agent into multiple incompetent veins of leg | 246 | $144 | $500 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 236 | $89 | $400 |
| Echocardiogram, transthoracic | 213 | $141 | $1,300 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 205 | $55 | $395 |
| Ultrasonic guidance during surgery | 204 | $141 | $500 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 199 | $1,073 | $3,750 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 199 | $626 | $798 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 190 | $826 | $5,500 |
| Office visit, established patient (20-29 min) | 141 | $62 | $140 |
| Hospital follow-up visit, high complexity | 120 | $92 | $190 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 104 | $133 | $600 |
| Remote pacemaker/defibrillator monitoring, 90 days | 95 | $15 | $125 |
| Remote pacemaker monitoring, 90 days | 94 | $19 | $125 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 94 | $17 | $80 |
| New patient office visit (45-59 min) | 93 | $116 | $310 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 87 | $27 | $145 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 61 | $20 | $125 |
| Initial hospital admission, high complexity | 56 | $134 | $400 |
| Programming of dual lead pacemaker system | 49 | $56 | $225 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 40 | $1,290 | $6,000 |
| Ultrasound of both sides of head and neck blood flow | 38 | $138 | $650 |
| New patient office visit (30-44 min) | 27 | $76 | $210 |
| Annual wellness visit, follow-up | 26 | $126 | $333 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 25 | $20 | $83 |
| Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance | 22 | $1,094 | $4,290 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 19 | $6 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $2 | $120 |
| Office visit, established patient, complex (40-54 min) | 18 | $116 | $375 |
| External shock to heart to regulate heart beat | 16 | $84 | $571 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $83 | $350 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for cardiovascular disease in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lavergne is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 11% in TX), and high industry engagement (speaking/promotional, top 5%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lavergne experienced with office visit, established patient (30-39 min)?
Does Dr. Lavergne receive payments from pharmaceutical companies?
How do Dr. Lavergne's costs compare to other cardiovascular diseases in The Woodlands?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology